General information about company

Name of The CompanyTATVA CHINTAN PHARMA CHEM LIMITED
BSE Scrip Code543321
NSE SymbolTATVA
MSE SymbolNOTLISTED
Date of Start of Financial Year01-04-2023
Date of End of Financial Year31-03-2024
Reporting PeriodFirst half yearly
Date of Start of Reporting Period01-04-2023
Date of End of Reporting Period30-09-2023
Level of rounding to be used in disclosing related party transactionsMillions
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes



(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.






Related party transactions

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investmentsNotes
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment )Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1Tatva Chintan Pharma Chem LimitedAABCT0623NTatva Chintan USA Inc.ZZZZZ9999ZWholly owned SubsidiarySale of goods or services2000Approved259.2522159.463755.1771Textual Information(1)
2Tatva Chintan Pharma Chem LimitedAABCT0623NTatva Chintan USA Inc.ZZZZZ9999ZWholly owned SubsidiaryInvestmentNot Applicable 06.6566.656Textual Information(2)
3Tatva Chintan Pharma Chem LimitedAABCT0623NTatva Chintan Europe B.V.ZZZZZ9999ZWholly owned SubsidiarySale of goods or services2000Approved175.7044136.065753.7726Textual Information(3)
4Tatva Chintan Pharma Chem LimitedAABCT0623NTatva Chintan Europe B.V.ZZZZZ9999ZWholly owned SubsidiaryInvestmentNot Applicable 00.00950.0095Textual Information(4)
5Tatva Chintan Pharma Chem LimitedAABCT0623NChintan Nitinkumar ShahAGQPS0271DPromoter - Chairman and Managing DirectorRemunerationNot Applicable 8.25160.76330.7633Textual Information(5)
6Tatva Chintan Pharma Chem LimitedAABCT0623NChintan Nitinkumar ShahAGQPS0271DPromoter - Chairman and Managing DirectorDividend paidNot Applicable 9.794400Textual Information(6)
7Tatva Chintan Pharma Chem LimitedAABCT0623NAjaykumar Mansukhlal PatelACSPP6803CPromoter - Wholetime DirectorRemunerationNot Applicable 8.25160.76330.7633Textual Information(7)
8Tatva Chintan Pharma Chem LimitedAABCT0623NAjaykumar Mansukhlal PatelACSPP6803CPromoter - Wholetime DirectorAny other transactionReimbursement of office expensesNot Applicable 0.041700Textual Information(8)
9Tatva Chintan Pharma Chem LimitedAABCT0623NAjaykumar Mansukhlal PatelACSPP6803CPromoter - Wholetime DirectorDividend paidNot Applicable 800Textual Information(9)
10Tatva Chintan Pharma Chem LimitedAABCT0623NShekhar Rasiklal SomaniAKRPS2524APromoter - Wholetime DirectorRemunerationNot Applicable 8.25160.76330.7633Textual Information(10)
11Tatva Chintan Pharma Chem LimitedAABCT0623NShekhar Rasiklal SomaniAKRPS2524APromoter - Wholetime DirectorAny other transactionReimbursement of office expensesNot Applicable 0.18510.03050.0215Textual Information(11)
12Tatva Chintan Pharma Chem LimitedAABCT0623NShekhar Rasiklal SomaniAKRPS2524APromoter - Wholetime DirectorDividend paidNot Applicable 10.793700Textual Information(12)
13Tatva Chintan Pharma Chem LimitedAABCT0623NAshok BothraAGFPB9662EChief Financial OfficerRemunerationNot Applicable 3.33380.40220.2813Textual Information(13)
14Tatva Chintan Pharma Chem LimitedAABCT0623NAshok BothraAGFPB9662EChief Financial OfficerAny other transactionReimbursement of office expensesNot Applicable 0.000900Textual Information(14)
15Tatva Chintan Pharma Chem LimitedAABCT0623NIshwar NayiAPGPN4130HCompany Secretary and Compliance OfficerRemunerationNot Applicable 0.47620.05890.0774Textual Information(15)
16Tatva Chintan Pharma Chem LimitedAABCT0623NIshwar NayiAPGPN4130HCompany Secretary and Compliance OfficerAny other transactionReimbursement of office expensesNot Applicable 0.005400Textual Information(16)
17Tatva Chintan Pharma Chem LimitedAABCT0623NManher Chimanlal DesaiABTPD1932ENon-Executive Independent DirectorAny other transactionSitting feesNot Applicable 0.15500Textual Information(17)
18Tatva Chintan Pharma Chem LimitedAABCT0623NSubhash Ambubhai PatelADFPP1273NNon-Executive Independent DirectorAny other transactionSitting feesNot Applicable 0.16500Textual Information(18)
19Tatva Chintan Pharma Chem LimitedAABCT0623NAvani Rajesh UmattAAHPU9204BNon-Executive Independent DirectorAny other transactionSitting feesNot Applicable 0.13500Textual Information(19)
20Tatva Chintan Pharma Chem LimitedAABCT0623NDarshana Nitinkumar ShahANCPS1560JPromoters GroupDividend paidNot Applicable 0.079300Textual Information(20)
21Tatva Chintan Pharma Chem LimitedAABCT0623NShital Chintan ShahAFOPS7110QPromoters GroupDividend paidNot Applicable 0.46200Textual Information(21)
22Tatva Chintan Pharma Chem LimitedAABCT0623NPriti Ajay PatelAEDPP1295HPromoters GroupDividend paidNot Applicable 1.800Textual Information(22)
23Tatva Chintan Pharma Chem LimitedAABCT0623NKajal Shekhar SomaniAAKPD0835EPromoters GroupDividend paidNot Applicable 0.436200Textual Information(23)
24Tatva Chintan Pharma Chem LimitedAABCT0623NSamirkumar Rasiklal SomaniABKPS9105RPromoters GroupDividend paidNot Applicable 0.00100Textual Information(24)
25Tatva Chintan Pharma Chem LimitedAABCT0623NShitalkumar Rasiklal SomaniABKPS9106NPromoters GroupDividend paidNot Applicable 0.001700Textual Information(25)
26Tatva Chintan Pharma Chem LimitedAABCT0623NAjay Mansukhlal Patel HUFAAGHA5159JPromoters GroupDividend paidNot Applicable 1.430700Textual Information(26)
27Tatva Chintan Pharma Chem LimitedAABCT0623NChintan N Shah HUFAACHC2329APromoters GroupDividend paidNot Applicable 0.89500Textual Information(27)
28Tatva Chintan Pharma Chem LimitedAABCT0623NShah Shimoni ChintanEGYPS5156MRelative of Key Managerial PersonnelRemunerationNot Applicable 0.150.0230.023Textual Information(28)
29Tatva Chintan Pharma Chem LimitedAABCT0623NShah Shimoni ChintanEGYPS5156MRelative of Key Managerial PersonnelAny other transactionReimbursement of office expensesNot Applicable 0.000900Textual Information(29)
30Tatva Chintan Pharma Chem LimitedAABCT0623NAryan Shekhar SomaniNDHPS3925PRelative of Key Managerial PersonnelRemunerationNot Applicable 0.082700.023Textual Information(30)
Total value of transaction during the reporting period498.1371